CDTX — Cidara Therapeutics Share News
0.000.00%
Last trade - 00:00- $6.95bn
- $6.53bn
- $1.28m
Merck bets on flu prevention with about $9.2 billion deal for Cidara Therapeutics
Brief: Merck To Acquire Cidara Therapeutics, Diversifying Its Portfolio To Include Late-Phase Antiviral Agent
Deals of the day-Mergers and acquisitions
Cidara shares double after report Merck nears buyout deal
Merck nearing deal for Cidara, FT reports
Brief: Merck Nearing Deal For Flu Treatment Start-Up Cidara - FT
Cidara Therapeutics Q3 net loss widens
Brief: Cidara Therapeutics Q3 Operating Expenses USD 88.628 Million
U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity
U.S. STOCKS ON THE MOVE-InterDigital, Scholar Rock, Live Nation
U.S. STOCKS ON THE MOVE-Whirlpool, IREN, Cidara
Cidara rises after US FDA grants 'breakthrough tag' to flu prevention drug
Brief: Cidara Therapeutics Receives Barda Award Valued Up To $339 Million
Brief: Cidara Therapeutics Announces First Participants Dosed In Phase 3 Anchor Trial Evaluating Cd388
Cidara Therapeutics jumps after accelerating late-stage trial for influenza therapy
Brief: Cidara Therapeutics To Expand And Accelerate Phase 3 Trial Of CD388
Brief: Cidara Shares Phase 2B CD388 Data, H5N1 Preclinical Results At ISRV’s 8th AVG & 3rd IMRP 2025 Meeting
Cidara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Cidara Therapeutics Q2 Operating Expenses USD 27.384 Million